US 12070472
Treatment of drug resistant proliferative diseases with telomerase mediated telomere altering compounds
granted A61KA61K31/7076A61K31/7105
Quick answer
US patent 12070472 (Treatment of drug resistant proliferative diseases with telomerase mediated telomere altering compounds) held by The Board of Regents of the University of Texas System expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Aug 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/7076, A61K31/7105, A61K45/06, A61K9/0019